DSG3 and pemphigus: In conclusion, we believe that the utilization of recombinant DSG1 and DSG3 proteins by ELISA should be used with caution to monitor disease severity and response to therapy, although it remains a high specific test for the initial diagnosis of pemphigus and the identification of a change in the clinical phenotype of this condition.